Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations
暂无分享,去创建一个
Philip Greenland | Valentin Fuster | V. Fuster | S. Grundy | Sidney C. Smith | P. Greenland | R. Pasternak | Scott M. Grundy | Richard C. Pasternak
[1] P. Wilson,et al. Diabetes mellitus and coronary heart disease. , 2001, Endocrinology and metabolism clinics of North America.
[2] Teven,et al. MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .
[3] S. Grundy. Primary prevention of coronary heart disease: integrating risk assessment with intervention. , 1999, Circulation.
[4] A. Döring,et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.
[5] R. Krauss,et al. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. , 1999, Circulation.
[6] B. Davis,et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. , 1998, Circulation.
[7] R. Collins,et al. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.
[8] G. Mancia,et al. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. , 1998, Atherosclerosis.
[9] E. Giltay,et al. Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[10] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[11] A. Karter,et al. Ischemic heart disease and stroke mortality in African-American, Hispanic, and non-Hispanic white men and women, 1985 to 1991. , 1998, The Western journal of medicine.
[12] G. Montalescot,et al. Fibrinogen as a risk factor for coronary heart disease. , 1998, European heart journal.
[13] B. Horne,et al. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. , 1998, Journal of the American College of Cardiology.
[14] A. Gotto,et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.
[15] S M Grundy,et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. , 1998, Circulation.
[16] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[17] Grundy,et al. Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissue , 1998, Journal of internal medicine.
[18] S. Grundy. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. , 1998, The American journal of cardiology.
[19] J. Hokanson,et al. Hypertriglyceridemia as a cardiovascular risk factor. , 1998, The American journal of cardiology.
[20] E. Eaker. Psychosocial risk factors for coronary heart disease in women. , 1998, Cardiology clinics.
[21] M. A. White,et al. Arabian Peninsula men tend to insulin resistance and cardiovascular risk seen in South Asians , 1998, Tropical medicine & international health : TM & IH.
[22] S. Haffner. Management of Dyslipidemia in Adults With Diabetes , 1998, Diabetes Care.
[23] W. Roos,et al. Development of a new microparticle‐enhanced turbidimetric assay for C‐reactive protein with superior features in analytical sensitivity and dynamic range , 1998, Journal of clinical laboratory analysis.
[24] A. von Eckardstein,et al. The emergence of triglycerides as a significant independent risk factor in coronary artery disease. , 1998, European heart journal.
[25] Claude Bouchard,et al. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary , 1998 .
[26] B. Mozes,et al. Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli Coronary Artery Bypass (ISCAB) Study Consortium. , 1998, The American journal of cardiology.
[27] J. Gerich. Metabolic abnormalities in impaired glucose tolerance. , 1997, Metabolism: clinical and experimental.
[28] I. Ockene,et al. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. , 1997, Circulation.
[29] R. Eckel,et al. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. , 1997, Circulation.
[30] K. King. Psychologic and social aspects of cardiovascular disease , 1997, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.
[31] G. Fletcher. How to implement physical activity in primary and secondary prevention. A statement for healthcare-professionals from the Task Force on Risk-reduction, American Heart Association. , 1997, Circulation.
[32] J. Witteman,et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. , 1997, JAMA.
[33] H. Krumholz,et al. Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee. , 1997, Circulation.
[34] Terje R Pedersen,et al. Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.
[35] D. Labarthe,et al. Greater incidence of hospitalized myocardial infarction among Mexican Americans than non-Hispanic whites. The Corpus Christi Heart Project, 1988-1992. , 1997, Circulation.
[36] M. Evans,et al. Body weight and mortality among women. , 1997, Canadian family physician Medecin de famille canadien.
[37] Detection. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .
[38] R M Peshock,et al. Relationship of Generalized and Regional Adiposity to Insulin Sensitivity in Men With NIDDM , 1996, Diabetes.
[39] D L Rothman,et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. , 1996, The New England journal of medicine.
[40] B. Davis,et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.
[41] R. Krauss,et al. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. , 1996, JAMA.
[42] F. Mayet,et al. Risk factors leading to coronary heart disease among the black, Indian and white peoples of Durban. , 1996, Journal of human hypertension.
[43] P. Wilson,et al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. , 1996, JAMA.
[44] J. Després,et al. The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men , 1996, Diabetes Care.
[45] L. Kuller,et al. Coronary artery disease in IDDM. Gender differences in risk factors but not risk. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[46] K. Robinson,et al. Homocysteine and coronary atherosclerosis. , 1996, Journal of the American College of Cardiology.
[47] N. Rigotti,et al. Cigarette smoking and coronary heart disease: risks and management. , 1996, Cardiology clinics.
[48] P. Macfarlane,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .
[49] J. Macintyre,et al. Physical Fitness and All-Cause Mortality , 1995 .
[50] V. Fuster,et al. Preventing heart attack and death in patients with coronary disease. , 1995, Circulation.
[51] E. Boerwinkle,et al. No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[52] W. Vermaak,et al. Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. , 1995, Clinical chemistry.
[53] D Spiegelman,et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. , 1995, American journal of epidemiology.
[54] R S Paffenbarger,et al. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. , 1995, JAMA.
[55] A. Lindgren,et al. Plasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acid , 1995, Journal of internal medicine.
[56] T. Meade,et al. Fibrinogen in ischaemic heart disease. , 1995, European heart journal.
[57] R. Krauss,et al. Dense low density lipoproteins and coronary artery disease. , 1995, The American journal of cardiology.
[58] P. Macfarlane,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.
[59] J. Staessen,et al. Relation of left ventricular mass and filling to exercise blood pressure and rest blood pressure. , 1995, The American journal of cardiology.
[60] M. Emond,et al. Long‐term Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry , 1994, Circulation.
[61] P. Poole‐Wilson,et al. Prevention of coronary heart disease in clinical practice , 1994 .
[62] G. Dahlén. Lp(a) lipoprotein in cardiovascular disease. , 1994, Atherosclerosis.
[63] R. Bergman,et al. Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[64] J. Stengård,et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.
[65] C. Burchfiel,et al. Physical activity and 23-year incidence of coronary heart disease morbidity and mortality among middle-aged men. The Honolulu Heart Program. , 1994, Circulation.
[66] M. Laakso,et al. Isolated Low HDL Cholesterol: An Insulin-Resistant State , 1994, Diabetes.
[67] D. Labarthe,et al. Greater case-fatality after myocardial infarction among Mexican Americans and women than among non-Hispanic whites and men. The Corpus Christi Heart Project. , 1994, American journal of epidemiology.
[68] S M Grundy,et al. Excess body weight. An under-recognized contributor to dyslipidemia in white American women. , 1994, Archives of internal medicine.
[69] M. Law,et al. Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study , 1994, BMJ.
[70] R. Bhopal,et al. Coronary risk in a British Punjabi population: comparative profile of non-biochemical factors. , 1994, International journal of epidemiology.
[71] C. Bouchard,et al. Physical activity, fitness, and coronary heart disease. , 1994 .
[72] L. Wilkins,et al. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994, Circulation.
[73] P. Ridker,et al. A prospective study of lipoprotein(a) and the risk of myocardial infarction. , 1993, JAMA.
[74] Pi-Sunyer Fx. Short-Term Medical Benefits and Adverse Effects of Weight Loss , 1993 .
[75] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[76] S. Grundy,et al. Excess body weight: An underrecognized contributor to high blood cholesterol levels in white American men , 1993 .
[77] T. W. Smith,et al. Cynical hostility and cardiovascular reactivity during self‐disclosure. , 1993, Psychosomatic medicine.
[78] J S Yudkin,et al. Impaired glucose tolerance. , 1990, BMJ.
[79] I. Piña,et al. Statement on exercise. Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart association. , 1992, Circulation.
[80] P. Rust,et al. Body mass index and body girths as predictors of mortality in black and white women. , 1992, Archives of internal medicine.
[81] G. Reaven. Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease. , 1991, American heart journal.
[82] R. DeFronzo,et al. Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.
[83] M. Austin. Plasma triglyceride and coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[84] K. Anderson,et al. An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.
[85] W. Kannel,et al. Parental history is an independent risk factor for coronary artery disease: the Framingham Study. , 1990, American heart journal.
[86] M. King,et al. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.
[87] S. Haffner,et al. Overweight and mortality in Mexican Americans. , 1990, International journal of obesity.
[88] R. Campbell,et al. Coronary heart disease in high-risk populations: lessons from Finland. , 1990, European heart journal.
[89] R S Paffenbarger,et al. Physical fitness and all-cause mortality. A prospective study of healthy men and women. , 1989, JAMA.
[90] A. Jaffe,et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. , 1989, Journal of the American College of Cardiology.
[91] J. Huttunen,et al. Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study. , 1989, The American journal of cardiology.
[92] Ronald M. Lauer,et al. National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: executive summary. National Heart, Lung and Blood Institute, National Institutes of Health. , 1991, Archives of internal medicine.
[93] A. Jaffe,et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. , 1989, Journal of the American College of Cardiology.
[94] P. Wilson,et al. Leisure time physical activity in the Framingham Offspring Study. Description, seasonal variation, and risk factor correlates. , 1989, American journal of epidemiology.
[95] G. Rosenhamer,et al. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. , 2009, Acta medica Scandinavica.
[96] G. Fraser,et al. Determinants of ischemic heart disease in Seventh-day Adventists: a review. , 1988, The American journal of clinical nutrition.
[97] L. Landsberg,et al. Mechanisms in obesity-related hypertension: role of insulin and catecholamines. , 1988, American journal of hypertension.
[98] T. Farag. Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.
[99] J. Neaton,et al. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.
[100] R. D'Agostino,et al. Physical activity and physical demand on the job and risk of cardiovascular disease and death: the Framingham Study. , 1986, American heart journal.
[101] W. Castelli,et al. The triglyceride issue: a view from Framingham. , 1986, American heart journal.
[102] S. Blair,et al. Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. , 1985, American heart journal.
[103] H. Blackburn,et al. The seven countries study: 2,289 deaths in 15 years. , 1984, Preventive medicine.
[104] S. Lillioja,et al. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. , 1984, The Journal of clinical investigation.
[105] I. Ringqvist,et al. Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). , 1983, The Journal of clinical investigation.
[106] I. Ringqvist,et al. Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry , 1982, Circulation.
[107] P. Bennett,et al. Mortality as a function of obesity and diabetes mellitus. , 1982, American journal of epidemiology.
[108] C. G. Blomqvist,et al. Statement on exercise , 1982 .
[109] E. Thaulow,et al. Natural history of cornary artery disease studied by coronary arteriography. A seven-year study of 795 patients. , 1981, Acta medica Scandinavica.
[110] W. Kannel,et al. Some health benefits of physical activity. The Framingham Study. , 1979, Archives of internal medicine.
[111] D L McGee,et al. Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study , 1979, Diabetes Care.
[112] D L McGee,et al. Diabetes and Cardiovascular Risk Factors: The Framingham Study , 1979, Circulation.
[113] W. Kannel,et al. Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.
[114] M Marmot,et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. , 1977, The American journal of cardiology.
[115] S. Syme,et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality. , 1975, American journal of epidemiology.
[116] S. Syme,et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. , 1975, American journal of epidemiology.
[117] A. Keys. CORONARY HEART DISEASE IN SEVEN COUNTRIES , 1971, The Medical journal of Australia.
[118] S. Bondurant. Symposium on Research on Acute Myocardial Infarction , 1970 .
[119] F. Epstein,et al. EPIDEMIOLOGICAL STUDIES OF CARDIOVASCULAR DISEASE IN A TOTAL COMMUNITY--TECUMSEH, MICHIGAN. , 1965, Annals of internal medicine.
[120] W. H. Phelan,et al. A Longitudinal Study of Coronary Heart Disease , 1963, Circulation.
[121] W. Kannel,et al. Cigarette Smoking and Coronary Heart Disease , 1962 .
[122] J. Stamler,et al. Prevalence and incidence of coronary heart disease in strata of the labor force of a Chicago industrial corporation. , 1960, Journal of chronic diseases.